Erectile dysfunction, physical activity and metabolic syndrome: differences in markers of atherosclerosis

Hanna Pohjantähti-Maaroos, Ari Palomäki, Juha Hartikainen, Hanna Pohjantähti-Maaroos, Ari Palomäki, Juha Hartikainen

Abstract

Background: Erectile dysfunction (ED), impaired arterial elasticity, elevated resting heart rate as well as increased levels of oxidized LDL and fibrinogen associate with future cardiovascular events. Physical activity is crucial in the prevention of cardiovascular diseases (CVD), while metabolic syndrome (MetS) comprises an increased risk for CVD events. The aim of this study was to assess whether markers of subclinical atherosclerosis are associated with the presence of ED and MetS, and whether physical activity is protective of ED.

Methods: 57 MetS (51.3 ± 8.0 years) and 48 physically active (PhA) (51.1 ± 8.1 years) subjects participated in the study. ED was assessed by the International Index of Erectile Function (IIEF) questionnaire, arterial elasticity by a radial artery tonometer (HDI/PulseWave™ CR-2000) and circulating oxLDL by a capture ELISA immunoassay. Fibrinogen and lipids were assessed by validated methods. The calculation of mean daily energy expenditure of physical exercise was based on a structured questionnaire.

Results: ED was more often present among MetS compared to PhA subjects, 63.2% and 27.1%, respectively (p < 0.001). Regular physical exercise at the level of > 400 kcal/day was protective of ED (OR 0.12, 95% CI 0.017-0.778, p = 0.027), whereas increased fibrinogen (OR 4.67, 95% CI 1.171-18.627, p = 0.029) and elevated resting heart rate (OR 1.07, 95% CI 1.003-1.138, p = 0.04) were independently associated with the presence of ED. In addition, large arterial elasticity (ml/mmHgx10) was lower among MetS compared to PhA subjects (16.6 ± 4.0 vs. 19.6 ± 4.2, p < 0.001), as well as among ED compared to non-ED subjects (16.7 ± 4.6 vs. 19.0 ± 3.9, p = 0.008). Fibrinogen and resting heart rate were highest and large arterial elasticity lowest among subjects with both MetS and ED.

Conclusions: Markers of subclinical atherosclerosis associated with the presence of ED and were most evident among subjects with both MetS and ED. Thus, especially MetS patients presenting with ED should be considered at high risk for CVD events. Physical activity, on its part, seems to be protective of ED.

Trial registration: ClinicalTrials.gov NCT01119404.

Figures

Figure 1
Figure 1
Prevalence of erectile dysfunction (ED) among metabolic syndrome (MetS) and physically active (PhA) subjects.
Figure 2
Figure 2
Fibrinogen levels (g/L) between the study groups (n = 105). Mean ± SEM is presented. P values after adjustment for age, smoking, blood pressure, established CVD, diabetes and LDL cholesterol, a p < 0.001, b p < 0.01, c p < 0.05.
Figure 3
Figure 3
Resting heart rate (beats/min) between the study groups (n = 105). Mean ± SEM is presented. P values after adjustment for age, smoking, blood pressure, established CVD, diabetes and LDL cholesterol, b p < 0.01, c p < 0.05.
Figure 4
Figure 4
Large arterial elasticity (C1, ml/mmHgx10) between the study groups (n = 105). Mean ± SEM is presented. After adjustment for age, smoking, blood pressure, established CVD, diabetes and LDL cholesterol, the differences were not significant.

References

    1. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84:1381–1478. doi: 10.1152/physrev.00047.2003.
    1. Kirby M, Jackson G, Simonsen U. Endothelial dysfunction links erectile dysfunction to heart Disease. Int J Clin Pract. 2005;59:225–229. doi: 10.1111/j.1742-1241.2005.00453.x.
    1. Cohn J, Finkelstein S, McVeigh G, Morgan D, LeMay L, Robinson J, Mock J. Non-invasive Pulse Wave Analysis for the Early Detection of Vascular Disease. Hypertension. 1995;26:503–508.
    1. Boutouyrie P, Tropeano I, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients. A longitudinal study. Hypertension. 2002;39:10–15. doi: 10.1161/hy0102.099031.
    1. Van Popele N, Grobbee D, Bots M, Asmar R, Topouchian J, Reneman R, Hoeks A, Van der Kuip D, Hofman A, Witteman J. Association between arterial stiffness and atherosclerosis. The Rotterdam study. Stroke. 2001;32:454–460. doi: 10.1161/01.STR.32.2.454.
    1. Holvoet P, Mertens A, Verhamme P, Bogaerts K, Beyens G, Verhaeghe R, Collen D, Muls E, Van de Werf F. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2001;21:844–848. doi: 10.1161/01.ATV.21.5.844.
    1. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 2005;294:1799–1809.
    1. Cooney M, Vartiainen E, Laatikainen T, Juolevi A, Dudina A, Graham I. Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women. Am Heart J. 2010;159:612–619. doi: 10.1016/j.ahj.2009.12.029.
    1. Jackson G, Boon N, Eardley I, Kirby M, Dean J, Hackett G, Montorsi P, Montorsi F, Vlachopoulos C, Kloner R, Sharlip I, Miner M. Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int J Clin Pract. 2010;64:848–857. doi: 10.1111/j.1742-1241.2010.02410.x.
    1. Thompson I, Tangen C, Goodman P, Probstfield J, Moinpour C, Coltman C. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005;294:2996–3002. doi: 10.1001/jama.294.23.2996.
    1. Inman B, Sauver J, Jacobson D, McGree M, Nehra A, Lieber M, Roger V, Jacobsen S. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. 2009;84:108–113. doi: 10.4065/84.2.108.
    1. Araujo A, Hall S, Ganz P, Chiu G, Rosen R, Kupelian V, Travison T, McKinlay J. Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score. J Am Coll Cardiol. 2010;55:350–356. doi: 10.1016/j.jacc.2009.08.058.
    1. Montorsi P, Ravagnani PM, Galli S, Rotatori F, Briganti A, Salonia A, Rigatti P, Montorsi F. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol. 2005;96(Suppl):19M–23M.
    1. Sisson SB, Camhi SM, Church TS, Martin CK, Tudor-Locke C, Bouchard C, Earnest CP, Smith SR, Newton RL Jr, Rankinen T, Katzmarzyk PT. Leisure time sedentary behaviour, occupational/domestic physical activity and metabolic syndrome in U.S. men and women. Metab Syndr Relat Disord. 2009;7:529–536. doi: 10.1089/met.2009.0023.
    1. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K. for the DECODE study group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004;164:1066–1067. doi: 10.1001/archinte.164.10.1066.
    1. Third report of the National Cholesterol Education Program (NCEP) expert panel on. detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Final report. Circulation. 2002;106:3143–3421.
    1. Ainsworth B, Haskell W, Whitt M, Irwin M, Swartz A, Strath S, O'Brien W, Basset D, Schmitz K, Emplaincourt P, Jacobs D, Leon A. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32:498–516. doi: 10.1097/00005768-200009001-00009.
    1. Rosen R, Riley A, Wagner G, Osterloh I, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;6:822–830.
    1. Prisant LM, Pasi M, Jupin D, Prisant ME. Assessment of repeatability and correlates of arterial compliance. Blood Press Monit. 2000;7:231–235.
    1. Resnick LM, Militianu D, Cunnings AJ, Pipe JG, Evelhoch JL, Soulen RL, Lester MA. Pulse waveform analysis of arterial compliance: relation to other techniques, age, and metabolic variables. Am J Hypertens. 2000;13:1243–1249. doi: 10.1016/S0895-7061(00)01219-X.
    1. Wilson AM, O'Neal D, Nelson CL, Prior DL, Best JD, Jenkins AJ. Comparison of arterial assessments in low and high vascular disease groups. Am J Hypertens. 2004;17:285–291. doi: 10.1016/j.amjhyper.2003.10.009.
    1. Zimlichman R, Shargorodsky M, Boaz M, Duprez D, Rahn KH, Rizzoni D, Payeras AC, Hamm C, McVeigh G. Determination of arterial compliance using blood pressure waveform analysis with the CR-2000 system: reliability, repeatability, and establishment of normal values for healthy European population - the seven European sites study (SESS) Am J Hypertens. 2005;18:65–71.
    1. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. A prospective study of risk factors for erectile dysfunction. J Urol. 2006;176:217–221. doi: 10.1016/S0022-5347(06)00589-1.
    1. Kratzik CW, Lackner JE, Märk I, Rücklinger E, Schmidbauer J, Lunglmayr G, Schatzl G. How much physical activity is needed to maintain erectile function? Results of The Androx Vienna Municipality study. Eur Urol. 2009;55:509–517. doi: 10.1016/j.eururo.2008.02.020.
    1. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F, D'Armiento M, Giugliano D. Effect of lifestyle changes on erectile dysfunction in obese men. A randomized controlled trial. JAMA. 2004;291:2978–2984. doi: 10.1001/jama.291.24.2978.
    1. Teles AG, Carreira M, Alarcão V, Sociol D, Aragüés JM, Lopes L, Mascarenhas M, Costa JG. Prevalence, severity, and risk factors for erectile dysfunction in a representative sample of 3,548 Portuguese men aged 40 to 69 years attending primary healthcare centers: results of the Portuguese erectile dysfunction study. J Sex Med. 2008;5:1317–1324. doi: 10.1111/j.1743-6109.2007.00745.x.
    1. Christensen BS, Grønbaek M, Pedersen BV, Graugaard C, Frisch M, Horansanli K, Boylu U, Kendirci M, Miroglu C. Associations of unhealthy lifestyle factors with sexual inactivity and sexual dysfunctions in Denmark. J Sex Med. 2011. in press .
    1. Hadaegh F, Zabetian A, Khalili D, Safarkhani M, James WP, Azizi F. A new approach to compare the predictive power of metabolic syndrome defined by a joint interim statement versus its components for incident cardiovascular disease in Middle East Caucasian residents in Tehran. J Epidemiol Community Health. 2010. in press .
    1. Bal K, Öder M, Şahin A, Karataş C, Demir Ö, Can E, Gümüş B, Özer K, Şahin O, Esen A. Prevalence of metabolic syndrome and its association with erectile dysfunction among urologic patients: metabolic backgrounds of erectile dysfunction. Urology. 2007;69:356–360. doi: 10.1016/j.urology.2006.09.057.
    1. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120:151–157. doi: 10.1016/j.amjmed.2006.06.010.
    1. Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA. 2002;288:351–357. doi: 10.1001/jama.288.3.351.
    1. Düsing R. Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. Blood Press Suppl. 2003;2:29–34.
    1. Doğru MT, Başar MM, Simşek A, Yuvanç E, Güneri M, Ebinç H, Batislam E. Effects of statin treatment on serum sex steroids levels and autonomic and erectile function. Urology. 2008;71:703–707. doi: 10.1016/j.urology.2007.11.059.
    1. Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis. 2003;168:351–358. doi: 10.1016/S0021-9150(03)00134-5.
    1. Church TS, Finley CE, Earnest CP, Kampert JB, Gibbons LW, Blair SN. Relative associations of fitness and fatness to fibrinogen, white blood cell count, uric acid and metabolic syndrome. Int J Obes. 2002;26:805–813.
    1. Myint PK, Luben RN, Wareham NJ, Welch AA, Bingham SA, Khaw KT. Physical activity and fibrinogen concentrations in 23,201 men and women in the EPIC-Norfolk population-based study. Atherosclerosis. 2008;198:419–425. doi: 10.1016/j.atherosclerosis.2007.09.021.
    1. Sinha S, Luben RN, Welch A, Bingham S, Wareham NJ, Day NE, Khaw KT. Fibrinogen and cigarette smoking in men and women in the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population. Eur J Cardiovasc Prev Rehabil. 2005;12:144–150.
    1. Vlachopoulos C, Aznaouridis K, Ioakeimidis N, Rokkas K, Vasiliadou C, Alexopoulos N, Stefanadi E, Askitis A, Stefanadis C. Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. Eur Heart J. 2006;27:2640–2648. doi: 10.1093/eurheartj/ehl341.
    1. Pohjantähti-Maaroos H, Palomäki A, Kankkunen P, Laitinen R, Husgafvel S, Oksanen K. Circulating oxidized low-density lipoproteins and arterial elasticity: comparison between men with metabolic syndrome and physically active counterparts. Cardiovasc Diabetol. 2010;9:41. doi: 10.1186/1475-2840-9-41.
    1. Ge JY, Li XL, Zhang HF, Xu Q, Tong M, Wang JG. Elasticity indices of large and small arteries in relation to the metabolic syndrome in Chinese. Am J Hypertens. 2008;21:143–147. doi: 10.1038/ajh.2007.26.
    1. Kaya C, Ergelen M, Ilktac A, Karaman I. Impaired elasticity of aorta in patients with erectile dysfunction. Urology. 2007;70:558–562. doi: 10.1016/j.urology.2007.04.018.
    1. Vlachopoulos C, Aznaouridis K, Ioakeimidis N, Rokkas K, Tsekoura D, Vasiliadou C, Stefanadi E, Askitis A, Stefanadis C. Arterial function and intima-media thickness in hypertensive patients with erectile dysfunction. J Hypertens. 2008;26:1829–1836. doi: 10.1097/HJH.0b013e3283050886.
    1. Pohjantähti-Maaroos H, Palomäki A. Comparison of metabolic syndrome subjects with and without erectile dysfunction - levels of circulating oxidised LDL and arterial elasticity. Int J Clin Pract. 2011;65:274–280. doi: 10.1111/j.1742-1241.2010.02595.x.
    1. Kaiser D, Billups K, Mason C, Wetterling R, Lundberg J, Bank A. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol. 2004;43:179–184. doi: 10.1016/j.jacc.2003.07.042.
    1. Yavuzgil O, Altay B, Zoghi M, Gürgün C, Kayıkçıoğlu M, Kültürsay H. Endothelial function in patients with vasculogenic erectile dysfunction. Int J Cardiol. 2005;103:19–26. doi: 10.1016/j.ijcard.2004.07.004.
    1. Sugawara J, Inoue H, Haysashi K, Yokoi T, Kono I. Effect of low-intensity aerobic exercise training on arterial compliance in postmenopausal women. Hypertens Res. 2004;27:897–901. doi: 10.1291/hypres.27.897.
    1. Elosua R, Molina L, Fito M, Arquer A, Sanchez-Quesada JL, Covas MI, Ordonez-Llanos J, Marrugat J. Response of oxidative stress biomarkers to a 16-week aerobic physical activity program, and to acute physical activity, in healthy young men and women. Atherosclerosis. 2003;167:327–334. doi: 10.1016/S0021-9150(03)00018-2.
    1. Miyachi M, Kawano H, Sugawara J, Takahashi K, Hayashi K, Yamazaki K, Tabata I, Tanaka H. Unfavorable effects of resistance training on central arterial compliance. A randomized intervention study. Circulation. 2004;110:2858–2863. doi: 10.1161/01.CIR.0000146380.08401.99.
    1. Muñoz MD, Olcina G, Timón R, Robles MC, Caballero MJ, Maynar M. Effect of different exercise intensities on oxidative stress markers and antioxidant response in trained cyclists. J Sports Med Phys Fitness. 2010;50:93–98.
    1. Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, Reid J, Van Zwieten PA. The sympathetic nervous system and the metabolic syndrome. J Hypertens. 2007;25:909–920. doi: 10.1097/HJH.0b013e328048d004.
    1. Arnold JM, Fitchett DH, Howlett JG, Lonn EM, Tardif JC. Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes? Can J Cardiol. 2008;24(SupplA):3A–8A.
    1. Tomiyama H, Hashimoto H, Tanaka H, Matsumoto C, Odaira M, Yamada J, Yoshida M, Shiina K, Nagata M, Yamashina A. baPWV/cfPWV Collaboration Group. Synergistic relationship between changes in the pulse wave velocity and changes in the heart rate in middle-aged Japanese adults: a prospective study. J Hypertens. 2010;28:687–694. doi: 10.1097/HJH.0b013e3283369fe8.
    1. Corona G, Mannucci E, Forti G, Maggi M. Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases. Int J Androl. 2009;32:587–598. doi: 10.1111/j.1365-2605.2008.00951.x.
    1. Revnic CR, Nica AS, Revnic F. The impact of physical training on endocrine modulation, muscle physiology and sexual functions in elderly men. Arch Gerontol Geriatr. 2007;44(Suppl 1):339–342.
    1. Vlachopoulos C, Rokkas K, Ioakeimidis N, Stefanadis C. Inflammation, metabolic syndrome, erectile dysfunction and coronary artery disease: common links. Eur Urol. 2007;52:1590–1600. doi: 10.1016/j.eururo.2007.08.004.
    1. Cappelleri J, Rosen R, Smith M, Mishra A, Osterloh I. Diagnostic evaluation of the erectile function domain of the international index of erectile function. Urology. 1999;54:346–351. doi: 10.1016/S0090-4295(99)00099-0.
    1. O'Donnell AB, Araujo AB, Goldstein I, McKinlay JB. The validity of a single-question self-report of erectile dysfunction. Results from the Massachusetts Male Aging Study. J Gen Intern Med. 2005;20:515–519. doi: 10.1111/j.1525-1497.2005.0076.x.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi